These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37315712)

  • 1. Inhibition of OAT1/3 and CMPF uptake attenuates myocardial ischemia-induced chronic heart failure via decreasing fatty acid oxidation and the therapeutic effects of ruscogenin.
    Lai Q; Zhu X; Zhang L; Kou J; Liu F; Yu B; Li F
    Transl Res; 2023 Nov; 261():1-15. PubMed ID: 37315712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis.
    Mohan H; Brandt SL; Kim JH; Wong F; Lai M; Prentice KJ; Al Rijjal D; Magomedova L; Batchuluun B; Burdett E; Bhattacharjee A; Cummins CL; Belsham DD; Cox B; Liu Y; Wheeler MB
    Diabetes Obes Metab; 2019 Jan; 21(1):61-72. PubMed ID: 30062833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.
    Tang B; Zhang JG; Tan HY; Wei XQ
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29301869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furan fatty acid metabolite CMPF is associated with lower risk of type 2 diabetes, but not chronic kidney disease: a longitudinal population-based cohort study.
    Miao Z; Zeng FF; Tian Y; Xiao C; Yan Y; Jiang Z; Fu Y; Chen YM; Zheng JS
    Am J Clin Nutr; 2023 Sep; 118(3):637-645. PubMed ID: 37482300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.
    Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X
    J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of uremic toxin transport by organic anion transporters in the kidney.
    Deguchi T; Kusuhara H; Takadate A; Endou H; Otagiri M; Sugiyama Y
    Kidney Int; 2004 Jan; 65(1):162-74. PubMed ID: 14675047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1.
    Singh KK; Shukla PC; Yanagawa B; Quan A; Lovren F; Pan Y; Wagg CS; Teoh H; Lopaschuk GD; Verma S
    J Thorac Cardiovasc Surg; 2013 Sep; 146(3):702-9. PubMed ID: 23317938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease.
    Lopaschuk GD; Stanley WC
    Cardiovasc Drugs Ther; 2006 Dec; 20(6):433-9. PubMed ID: 17136490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP9 inhibition increases autophagic flux in chronic heart failure.
    Nandi SS; Katsurada K; Sharma NM; Anderson DR; Mahata SK; Patel KP
    Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1414-H1437. PubMed ID: 33064567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pure omega 3 polyunsaturated fatty acids (EPA, DPA or DHA) are associated with increased plasma levels of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) in a short-term study in women.
    Liu G; Gibson RA; Callahan D; Guo XF; Li D; Sinclair AJ
    Food Funct; 2020 Mar; 11(3):2058-2066. PubMed ID: 32142084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From the Cover: Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity.
    Wang X; Han L; Li G; Peng W; Gao X; Klaassen CD; Fan G; Zhang Y
    Toxicol Sci; 2018 Feb; 161(2):321-334. PubMed ID: 29045746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.
    Yue TL; Bao W; Jucker BM; Gu JL; Romanic AM; Brown PJ; Cui J; Thudium DT; Boyce R; Burns-Kurtis CL; Mirabile RC; Aravindhan K; Ohlstein EH
    Circulation; 2003 Nov; 108(19):2393-9. PubMed ID: 14557369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cardiac fatty acid oxidation in a mouse model with decreased malonyl-CoA sensitivity of CPT1B.
    van Weeghel M; Abdurrachim D; Nederlof R; Argmann CA; Houtkooper RH; Hagen J; Nabben M; Denis S; Ciapaite J; Kolwicz SC; Lopaschuk GD; Auwerx J; Nicolay K; Des Rosiers C; Wanders RJ; Zuurbier CJ; Prompers JJ; Houten SM
    Cardiovasc Res; 2018 Aug; 114(10):1324-1334. PubMed ID: 29635338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Branched chain amino acids exacerbate myocardial ischemia/reperfusion vulnerability via enhancing GCN2/ATF6/PPAR-α pathway-dependent fatty acid oxidation.
    Li Y; Xiong Z; Yan W; Gao E; Cheng H; Wu G; Liu Y; Zhang L; Li C; Wang S; Fan M; Zhao H; Zhang F; Tao L
    Theranostics; 2020; 10(12):5623-5640. PubMed ID: 32373236
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired renal organic anion transport 1 (SLC22A6) and its regulation following acute myocardial infarction and reperfusion injury in rats.
    Sirijariyawat K; Ontawong A; Palee S; Thummasorn S; Maneechote C; Boonphang O; Chatsudthipong V; Chattipakorn N; Srimaroeng C
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2342-2355. PubMed ID: 31125610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furan fatty acids - Beneficial or harmful to health?
    Xu L; Sinclair AJ; Faiza M; Li D; Han X; Yin H; Wang Y
    Prog Lipid Res; 2017 Oct; 68():119-137. PubMed ID: 29051014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry.
    Suzuki Y; Sasamoto Y; Yoshijima C; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K
    J Pharm Biomed Anal; 2020 May; 184():113202. PubMed ID: 32114159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of PPAR-α in the early stage of heart failure maintained myocardial function and energetics in pressure-overload heart failure.
    Kaimoto S; Hoshino A; Ariyoshi M; Okawa Y; Tateishi S; Ono K; Uchihashi M; Fukai K; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H305-H313. PubMed ID: 28011586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malonyl-CoA decarboxylase is a major regulator of myocardial fatty acid oxidation.
    Cuthbert KD; Dyck JR
    Curr Hypertens Rep; 2005 Dec; 7(6):407-11. PubMed ID: 16386195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
    Hopkins TA; Dyck JR; Lopaschuk GD
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.